Published 2 days ago • loading... • Updated 2 days ago

FDA Unveils Key Updates on Rare Disease Advances, Food Safety, and Medical Innovations

Summary by MyChesCo

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has released a series of announcements covering a wide range of initiatives and regulatory updates, reflecting the agency’s ongoing commitment to public health, safety, and innovation. Rare Disease Drug Development Educational Videos On Thursday, March 27, the FDA’s Learning and Education to Advance and Empower Rare Disease Drug Developers (LEADER 3D) initiative unveiled two new educ…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

Aletho News

Is the FDA salvageable?

By Maryanne Demasi, PhD | March 26, 2025 Dr Marty Makary—now confirmed as FDA Commissioner—inherits an agency that routinely approves drugs with questionable benefits. At Makary’s confirmation hearing on March 6th, senators repeatedly hailed the FDA as the “gold standard” of drug regulation—a phrase meant to reassure the public that approved drugs are significantly effective. But this claim is an illusion. In 2013, Jonathan J. Darrow, a Harvard …

2 days ago

Read Full Article